Christopher Bianco

Associate Professor of Medicine

West Virginia University Hospitals

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Christopher Bianco is an Associate Professor of Medicine at West Virginia University Hospitals in the United States. His research primarily focuses on advanced heart failure, pharmacotherapy interactions, and machine learning applications in cardiology. Recent publications include studies on the efficacy of levosimendan, trends in VA-ECMO use, and the impact of substance use disorders on heart failure readmissions. He is dedicated to advancing the understanding and treatment of cardiovascular diseases in complex patient populations.

Articles (12)

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (2)

Kara Piechowski

Marshall University

UNITED STATES

View details

Brian Hendricks

Director and Associate Professor

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Christopher Bianco

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Call to action for drug interactions between tirzepatide and heart failure guideline-directed medical therapy

The Efficacy and Safety of Levosimendan in Patients with Advanced Heart Failure: An Updated Meta-Analysis of Randomized Controlled Trials.

Applications of Machine Learning in Cardiology.

Sixteen-Year National Trends in Use and Outcomes of VA-ECMO in Cardiogenic Shock.

Quantitative single photon emission computed tomography derived standardized uptake values on 99mTc-PYP scan in patients with suspected ATTR cardiac amyloidosis.

Effect of Cocaine, Amphetamine, and Cannabis Use Disorders on 30-day Readmissions of Patients with Heart Failure.

In-Hospital Characteristics and 30-Day Readmissions for Acute Myocardial Infarction and Major Bleeding in Patients With Active Cancer

Apixaban and rivaroxaban use for atrial fibrillation in patients with obesity and BMI ≥50 kg/m2

Pre-existing cardiovascular disease increases risk of atrial arrhythmia and mortality in cancer patients treated with Ibrutinib.

Clinical and demographic factors associated with stimulant use disorder in a rural heart failure population.

Invasive Hemodynamic Monitoring in Cardiogenic Shock Is Associated With Lower In-Hospital Mortality.

Impact of cancer diagnosis on causes and outcomes of 5.9 million US patients with cardiovascular admissions.

Collaborators (2)

Kara Piechowski

Brian Hendricks

Make your next move.